Medpace Holdings, Inc. Medpace Holdings, Inc.

Medpace Holdings, Inc.

MEDP

Rang in Aktien #1221
Medpace Holdings, Inc., founded in Cincinnati, Ohio, in 1992, functions as a... Medpace Holdings, Inc., founded in Cincinnati, Ohio, in 1992, functions as a contract research organization (CRO) delivering clinical development and research services. The company assists pharmaceutical, biotechnology, and medical device clients throughout North America, Europe, and Asia. Its comprehensive suite of offerings covers the entire product lifecycle, from initial Phase I trials through to Phase IV post-market surveillance. Medpace's services include designing development programs, coordinating central laboratory functions, managing projects, navigating regulatory processes, overseeing clinical trials, handling data management and analytics, ensuring pharmacovigilance, aiding with new drug application submissions, and providing ongoing post-marketing clinical support. Furthermore, the company offers specialized bio-analytical laboratory testing, conducts clinical human pharmacology studies, provides imaging services, and delivers expert electrocardiography (ECG) reading for clinical research.
Aktienkurs
$655.91
Zuletzt synchronisiert: 2026-10-21
Marktkapitalisierung
$18.31B
Veränderung (1 Tag)
5.38%
Veränderung (1 Jahr)
19.97%
Land
US
Handel Medpace Holdings, Inc. (MEDP)

Kategorie

Healthcare
Kursverlauf für Medpace Holdings, Inc. (MEDP)
Höchster Schlusskurs: $615.44 am 2026-10-01

Niedrigster Schlusskurs: $28.30 am 2016-08-01
Kursverlauf der Aktie von Medpace Holdings, Inc. von 2016 bis 2026
Jährliche Kursentwicklung
Jahr Leistung
2026 (TTM) -4.71%
2025 64.84%
2024 15.73%
2023 41.41%
2022 -2.02%
2021 53.55%
2020 71.69%
2019 48.38%
2018 52.53%
2017 0.13%
2016 0.00%
Aktienkurs vergleichbarer Unternehmen oder Wettbewerber
Unternehmen Aktienkurs Veränderung 1J% Land
$694.53 22.45%
US
$234.00 7.29%
US
$416.01 121.26%
US
$21.16 49.45%
CN
$177.93 21.98%
US